An FDA memo said proposed prescription painkillers should fill an unmet medical need for patients who have no other safer options. The staff view was released in advance of an advisory panel meeting to consider Merck's Arcoxia, a drug in the same class as Vioxx. The FDA said it assumes all prescription NSAIDs carry an increased risk of cardiovascular problems.

Related Summaries